About this trial
This study aims to evaluate the effectiveness of a biophotonic cosmetic massage cream in reducing musculoskeletal foot pain in adults. Participants with pain in one or both feet attending the Podiatry Clinical Area of the University of Seville will be randomly assigned to receive either the investigational cream or a placebo cream with similar characteristics. The assigned product will be applied topically to the painful area twice daily for 10 consecutive days. Pain intensity, pressure pain threshold, foot function, and health-related quality of life will be assessed during the study.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Patients attending the Podiatry Clinical Area of the University of Seville.
Presence of musculoskeletal pain in one or both feet at the initial assessment.
Ability to understand the study information and provide written informed consent.
Disqualifiers
Foot pain of non-musculoskeletal origin, or pain mainly attributable to infectious, vascular, tumoral, severe neurological, or decompensated systemic diseases.
Wounds, ulcers, burns, dermatitis, skin infections, or any active skin disorder at the application site.
Known allergy, hypersensitivity, or previous adverse reaction to any component of the investigational cream or placebo.
Concomitant use of analgesic, anti-inflammatory, or topical treatments on the foot that may interfere with efficacy assessment, unless a washout period is established.
Trial design
Treatments tested in this trial
- Biophotonic cosmetic massage cream
- Placebo